vs

Side-by-side financial comparison of Life360, Inc. (LIF) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Life360, Inc. is the larger business by last-quarter revenue ($146.0M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). Life360, Inc. runs the higher net margin — 88.8% vs -38.1%, a 126.9% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs 20.2%). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 24.8%).

Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

LIF vs PRCT — Head-to-Head

Bigger by revenue
LIF
LIF
1.8× larger
LIF
$146.0M
$83.1M
PRCT
Growing faster (revenue YoY)
LIF
LIF
+6.2% gap
LIF
26.4%
20.2%
PRCT
Higher net margin
LIF
LIF
126.9% more per $
LIF
88.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
LIF
LIF
Annualised
LIF
36.6%
24.8%
PRCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LIF
LIF
PRCT
PRCT
Revenue
$146.0M
$83.1M
Net Profit
$129.7M
$-31.6M
Gross Margin
75.1%
64.9%
Operating Margin
6.1%
-4.1%
Net Margin
88.8%
-38.1%
Revenue YoY
26.4%
20.2%
Net Profit YoY
1425.9%
-27.9%
EPS (diluted)
$1.53
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LIF
LIF
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$146.0M
$76.4M
Q3 25
$124.5M
$83.3M
Q2 25
$115.4M
$79.2M
Q1 25
$103.6M
$69.2M
Q4 24
$115.5M
$68.2M
Q3 24
$92.9M
$58.4M
Q2 24
$84.9M
$53.4M
Net Profit
LIF
LIF
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$129.7M
$-29.8M
Q3 25
$9.8M
$-21.4M
Q2 25
$7.0M
$-19.6M
Q1 25
$4.4M
$-24.7M
Q4 24
$8.5M
$-18.9M
Q3 24
$7.7M
$-21.0M
Q2 24
$-11.0M
$-25.6M
Gross Margin
LIF
LIF
PRCT
PRCT
Q1 26
64.9%
Q4 25
75.1%
60.6%
Q3 25
78.0%
64.8%
Q2 25
78.4%
65.4%
Q1 25
80.6%
63.9%
Q4 24
74.0%
64.0%
Q3 24
75.4%
63.2%
Q2 24
75.0%
59.0%
Operating Margin
LIF
LIF
PRCT
PRCT
Q1 26
-4.1%
Q4 25
6.1%
-40.6%
Q3 25
4.6%
-27.8%
Q2 25
1.7%
-28.0%
Q1 25
2.1%
-39.7%
Q4 24
4.9%
-28.9%
Q3 24
-5.3%
-38.4%
Q2 24
-2.8%
-50.3%
Net Margin
LIF
LIF
PRCT
PRCT
Q1 26
-38.1%
Q4 25
88.8%
-39.1%
Q3 25
7.9%
-25.7%
Q2 25
6.1%
-24.7%
Q1 25
4.2%
-35.8%
Q4 24
7.4%
-27.6%
Q3 24
8.3%
-35.9%
Q2 24
-12.9%
-48.0%
EPS (diluted)
LIF
LIF
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$1.53
$-0.54
Q3 25
$0.11
$-0.38
Q2 25
$0.08
$-0.35
Q1 25
$0.05
$-0.45
Q4 24
$0.14
$-0.34
Q3 24
$0.09
$-0.40
Q2 24
$-0.15
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LIF
LIF
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$494.3M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$548.2M
$347.7M
Total Assets
$959.7M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LIF
LIF
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$494.3M
$286.5M
Q3 25
$455.7M
$294.3M
Q2 25
$432.7M
$302.7M
Q1 25
$168.9M
$316.2M
Q4 24
$159.2M
$333.7M
Q3 24
$159.0M
$196.8M
Q2 24
$160.8M
$214.1M
Total Debt
LIF
LIF
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
LIF
LIF
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$548.2M
$365.9M
Q3 25
$391.4M
$380.3M
Q2 25
$366.7M
$385.8M
Q1 25
$376.3M
$389.2M
Q4 24
$358.5M
$402.2M
Q3 24
$339.7M
$241.2M
Q2 24
$326.7M
$251.8M
Total Assets
LIF
LIF
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$959.7M
$508.1M
Q3 25
$787.5M
$511.5M
Q2 25
$753.6M
$513.1M
Q1 25
$455.4M
$519.4M
Q4 24
$441.6M
$534.0M
Q3 24
$427.4M
$374.1M
Q2 24
$405.9M
$374.4M
Debt / Equity
LIF
LIF
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LIF
LIF
PRCT
PRCT
Operating Cash FlowLast quarter
$36.8M
Free Cash FlowOCF − Capex
$36.6M
FCF MarginFCF / Revenue
25.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
0.28×
TTM Free Cash FlowTrailing 4 quarters
$86.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LIF
LIF
PRCT
PRCT
Q1 26
Q4 25
$36.8M
$-10.3M
Q3 25
$26.4M
$-6.6M
Q2 25
$13.3M
$-15.0M
Q1 25
$12.1M
$-17.0M
Q4 24
$12.3M
$-32.4M
Q3 24
$6.3M
$-18.8M
Q2 24
$3.3M
$-15.7M
Free Cash Flow
LIF
LIF
PRCT
PRCT
Q1 26
Q4 25
$36.6M
$-12.2M
Q3 25
$25.6M
$-9.5M
Q2 25
$12.7M
$-17.8M
Q1 25
$11.9M
$-18.8M
Q4 24
$11.2M
$-33.6M
Q3 24
$6.3M
$-19.0M
Q2 24
$3.2M
$-16.8M
FCF Margin
LIF
LIF
PRCT
PRCT
Q1 26
Q4 25
25.1%
-15.9%
Q3 25
20.6%
-11.4%
Q2 25
11.0%
-22.5%
Q1 25
11.5%
-27.2%
Q4 24
9.7%
-49.2%
Q3 24
6.8%
-32.6%
Q2 24
3.8%
-31.4%
Capex Intensity
LIF
LIF
PRCT
PRCT
Q1 26
Q4 25
0.2%
2.4%
Q3 25
0.6%
3.4%
Q2 25
0.6%
3.5%
Q1 25
0.1%
2.7%
Q4 24
1.0%
1.7%
Q3 24
0.0%
0.4%
Q2 24
0.1%
2.0%
Cash Conversion
LIF
LIF
PRCT
PRCT
Q1 26
Q4 25
0.28×
Q3 25
2.70×
Q2 25
1.90×
Q1 25
2.75×
Q4 24
1.45×
Q3 24
0.83×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LIF
LIF

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons